Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06727838

Study on Drug Interaction of Metformin Tablets and HRS-7535 Tablets in Healthy Human

A Single-center, Open-label, Fixed-sequence, Self-controlled Pharmacokinetics Study of Metformin and HRS-7535 in Healthy Subjects

Status
Not Yet Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
54 (estimated)
Sponsor
Shandong Suncadia Medicine Co., Ltd. · Industry
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This study was a single-center, open, fixed-sequence, self-controlled trial design conducted in healthy subjects.

Conditions

Interventions

TypeNameDescription
DRUGHRS-7535 tabletsHRS-7535 tablets.
DRUGMetformin Hydrochloride Extended-release TabletsMetformin Hydrochloride Extended-release Tablets.
DRUGMetformin Hydrochloride TabletsMetformin Hydrochloride Tablets.

Timeline

Start date
2024-12-01
Primary completion
2025-05-01
Completion
2025-05-01
First posted
2024-12-11
Last updated
2024-12-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06727838. Inclusion in this directory is not an endorsement.